Window on the Clearwater
Traditional news Today's technology

Advertisement

10-23-12

healthtalk.JPG - 5177 Bytes
htsponsors2.PNG - 6545 Bytes

New insights into breast cancer found

A careful analysis of genomic data further defined four primary subtypes of breast cancer, each with its own biology and survival outlook. One subtype shares many genetic features with high-grade serous ovarian cancer. The findings may help to guide future treatment strategies.

Each year about 1.3 million new cases of breast cancer arise worldwide, contributing to about 450,000 deaths, according to the World Health Organization. It's the most common cancer among women. Men can also develop breast cancer but account for a small fraction of cases. The majority of breast cancers are sporadic, meaning there is no family history of the disease. However, many genes can predispose a person to breast cancer.

For the new study, researchers performed a comprehensive genomic characterization of samples from 825 breast cancer patients. The extensive data were generated by The Cancer Genome Atlas (TCGA) Research Network, which consists of more than 150 researchers at dozens of institutions across the world. The study was a collaborative effort funded by NIH's National Cancer Institute (NCI) and National Human Genome Research Institute (NHGRI). The results appeared on October 4, 2012, in Nature.

In addition to identifying nearly all the genes previously implicated in breast cancer, the researchers implicated several novel genes, including TBX3, RUNX1, CBFB, AFF2, PIK3R1, PTPN22, PTPRD, NF1, SF3B1 and CCND3.

The scientists distinguished four main subtypes of breast cancer. Each subtype has its own biology and survival outlook. The 4 subtypes are called HER2-enriched (HER2E), Luminal A (LumA), Luminal B (LumB) and Basal-like.

The scientists found that the Basal-like subtype shares many genetic features with high-grade serous ovarian cancer, suggesting that the two cancers are of similar molecular origin. Serous ovarian cancer has proven difficult to treat. Computational analyses suggested compounds that might affect these cancers.

"The molecular similarity of one of the principal subtypes of breast cancer to that found in ovarian cancer gives us additional leverage to compare treatments and outcomes across these two cancers," says NCI Director Dr. Harold Varmus. "This treasure trove of genetic information will need to be examined in great detail to identify how we can use it functionally and clinically."

The broad scale of this study will lead to a deeper understanding of the changes essential for cancer progression. The researchers hope these discoveries will be a crucial step toward improving breast cancer therapies.

"The data generated by the TCGA program comprise a vast resource that investigators will be analyzing for years to come. The resource of information about breast cancer genomes will undoubtedly fuel myriad discoveries by the cancer research community," says NHGRI Director Dr. Eric D. Green.

--From the National Institute of Health

For further information on this and other health topics, visit the web site of the National Institute of Health at www.nih.gov.

Health Talk Archives...

Sponsored by:

brooksidead2.JPG - 15389 Bytes
cvhcad2.JPG - 13883 Bytes

Window on the Clearwater
P.O. Box 2444
Orofino, ID 83544

Telephone:
Orofino 476-0733
Fax: 208-476-4140

Email